Segovia, Romeo C.

HRN: 24-70-45  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2024
FLUCONAZOLE 50MG (CAP)
04/03/2024
04/06/2024
PO
50mgtab; 2 Tabsfor 10 Days
Q24
Oral Candidiasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: